CN111000933A - Composition formula for removing necrotic tissue, promoting granulation and preventing scars - Google Patents

Composition formula for removing necrotic tissue, promoting granulation and preventing scars Download PDF

Info

Publication number
CN111000933A
CN111000933A CN202010015411.3A CN202010015411A CN111000933A CN 111000933 A CN111000933 A CN 111000933A CN 202010015411 A CN202010015411 A CN 202010015411A CN 111000933 A CN111000933 A CN 111000933A
Authority
CN
China
Prior art keywords
parts
necrotic tissue
blood
scars
narcissus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010015411.3A
Other languages
Chinese (zh)
Inventor
潘志铁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202010015411.3A priority Critical patent/CN111000933A/en
Publication of CN111000933A publication Critical patent/CN111000933A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Husbandry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a composition formula for removing necrotic tissue, promoting granulation and preventing scars, which comprises the following raw materials in parts by weight: 5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax. The formula of the composition for removing the necrotic tissue and promoting tissue regeneration and preventing scars has the effects of astringing, diminishing inflammation, removing the necrotic tissue and promoting tissue regeneration and removing heat toxin, is used for treating scalds or mechanical wounds, can quickly and thoroughly dissipate heat of the wounds, enables blood vessels of the skin to contract, reduces exudation and edema, relieves pain, reduces blister formation and prevents scars formed on the wound surfaces.

Description

Composition formula for removing necrotic tissue, promoting granulation and preventing scars
Technical Field
The invention relates to the technical field of medicines, in particular to a formula of a composition for removing necrotic tissue, promoting granulation and preventing scars.
Background
At present, when treating a patient with trauma and serious infection, in order to ensure the life of the patient, the main treatment method is to excise the serious infection part, which causes great pain to the patient. And usually, scars are left on the affected parts after recovery, the cost is high, heavy psychological and physiological pain is brought to patients and family members, and a lot of inconvenience is brought to later life. Most western medicines are treated by taking antibiotic medicines to prevent wound infection, but the treatment effect is poor, and particularly, serious infected people take the antibiotic medicines for a long time, so that a lot of adverse reactions are easily caused, and a lot of side effects are caused. Therefore, people have great needs for traditional Chinese medicines for effectively treating scalds.
The information disclosed in this background section is only for enhancement of understanding of the general background of the invention and should not be taken as an acknowledgement or any form of suggestion that this information forms the prior art already known to a person skilled in the art.
Disclosure of Invention
The invention aims to provide a composition formula for removing necrotic tissue, promoting tissue regeneration and preventing scars, which aims to solve the technical problems in the prior art.
In order to achieve the purpose, the invention adopts the following technical scheme:
the invention provides a composition formula for removing necrotic tissue, promoting granulation and preventing scars, which comprises the following raw materials in parts by weight:
5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax.
As a further technical scheme, the feed comprises the following raw materials in parts by weight:
6.8-7.2 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax.
As a further technical scheme, the feed comprises the following raw materials in parts by weight:
5-8.5 parts of borneol, 9.2-10.5 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax.
As a further technical scheme, the feed comprises the following raw materials in parts by weight:
5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 16.5-16.8 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax.
As a further technical scheme, the feed comprises the following raw materials in parts by weight:
5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22.5-23.2 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax.
As a further technical scheme, the feed comprises the following raw materials in parts by weight:
5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7.8-8.2 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax.
As a further technical scheme, the feed comprises the following raw materials in parts by weight:
5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 1-1.2 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax.
As a further technical scheme, the feed comprises the following raw materials in parts by weight:
5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 12-14 parts of sesame oil and 12-14 parts of beeswax.
As a further technical scheme, the feed comprises the following raw materials in parts by weight:
5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12.5-13 parts of beeswax.
By adopting the technical scheme, the invention has the following beneficial effects:
the formula of the composition for removing the necrotic tissue and promoting tissue regeneration and preventing scars has the effects of astringing, diminishing inflammation, removing the necrotic tissue and promoting tissue regeneration and removing heat toxin, is used for treating scalds or mechanical wounds, can quickly and thoroughly dissipate heat of the wounds, enables blood vessels of the skin to contract, reduces exudation and edema, relieves pain, reduces blister formation and prevents scars formed on the wound surfaces.
Detailed Description
The technical solutions of the present invention will be described clearly and completely with reference to specific embodiments, and it should be understood that the described embodiments are a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
For the sake of brevity, only some numerical ranges are explicitly disclosed herein. However, any lower limit may be combined with any upper limit to form ranges not explicitly recited; and any lower limit may be combined with any other lower limit to form a range not explicitly recited, and similarly any upper limit may be combined with any other upper limit to form a range not explicitly recited. Also, although not explicitly recited, each point or individual value between endpoints of a range is encompassed within the range. Thus, each point or individual value can form a range not explicitly recited as its own lower or upper limit in combination with any other point or individual value or in combination with other lower or upper limits.
Example one
The embodiment provides a formula of a composition for removing necrotic tissue, promoting tissue regeneration and preventing scars, which comprises the following raw materials in parts by weight: 5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax. Through the quantitative compatibility of various traditional Chinese medicinal materials, the effective components of the raw medicinal materials generate obvious synergistic effect, have the effects of astringing, diminishing inflammation, removing the necrotic tissue, promoting granulation and removing heat toxin, are used for treating scalds or mechanical wounds, can quickly and thoroughly dissipate heat of the wounds, can cause the skin to contract blood vessels, reduce exudation and edema, relieve pain, reduce blister formation and prevent scars on the wound surfaces.
Example two
Specifically, the present embodiment provides a composition formula for removing necrotic tissue, promoting tissue regeneration, and preventing scars, which comprises the following raw materials by weight: 6.8-7.2 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax. Through the quantitative compatibility of various traditional Chinese medicinal materials, the effective components of the raw medicinal materials generate obvious synergistic effect, have the effects of astringing, diminishing inflammation, removing the necrotic tissue, promoting granulation and removing heat toxin, are used for treating scalds or mechanical wounds, can quickly and thoroughly dissipate heat of the wounds, can cause the skin to contract blood vessels, reduce exudation and edema, relieve pain, reduce blister formation and prevent scars on the wound surfaces.
EXAMPLE III
Specifically, the present embodiment provides a composition formula for removing necrotic tissue, promoting tissue regeneration, and preventing scars, which comprises the following raw materials in parts by weight: 5-8.5 parts of borneol, 9.2-10.5 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax. Through the quantitative compatibility of various traditional Chinese medicinal materials, the effective components of the raw medicinal materials generate obvious synergistic effect, have the effects of astringing, diminishing inflammation, removing the necrotic tissue, promoting granulation and removing heat toxin, are used for treating scalds or mechanical wounds, can quickly and thoroughly dissipate heat of the wounds, can cause the skin to contract blood vessels, reduce exudation and edema, relieve pain, reduce blister formation and prevent scars on the wound surfaces.
Example four
Specifically, the present embodiment provides a composition formula for removing necrotic tissue, promoting tissue regeneration, and preventing scars, which comprises the following raw materials by weight: 5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 16.5-16.8 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax. Through the quantitative compatibility of various traditional Chinese medicinal materials, the effective components of the raw medicinal materials generate obvious synergistic effect, have the effects of astringing, diminishing inflammation, removing the necrotic tissue, promoting granulation and removing heat toxin, are used for treating scalds or mechanical wounds, can quickly and thoroughly dissipate heat of the wounds, can cause the skin to contract blood vessels, reduce exudation and edema, relieve pain, reduce blister formation and prevent scars on the wound surfaces.
EXAMPLE five
The embodiment provides a formula of a composition for removing necrotic tissue, promoting tissue regeneration and preventing scars, which comprises the following raw materials in parts by weight: 5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22.5-23.2 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax. Through the quantitative compatibility of various traditional Chinese medicinal materials, the effective components of the raw medicinal materials generate obvious synergistic effect, have the effects of astringing, diminishing inflammation, removing the necrotic tissue, promoting granulation and removing heat toxin, are used for treating scalds or mechanical wounds, can quickly and thoroughly dissipate heat of the wounds, can cause the skin to contract blood vessels, reduce exudation and edema, relieve pain, reduce blister formation and prevent scars on the wound surfaces.
EXAMPLE six
The embodiment provides a formula of a composition for removing necrotic tissue, promoting tissue regeneration and preventing scars, which comprises the following raw materials in parts by weight: 5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7.8-8.2 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax. Through the quantitative compatibility of various traditional Chinese medicinal materials, the effective components of the raw medicinal materials generate obvious synergistic effect, have the effects of astringing, diminishing inflammation, removing the necrotic tissue, promoting granulation and removing heat toxin, are used for treating scalds or mechanical wounds, can quickly and thoroughly dissipate heat of the wounds, can cause the skin to contract blood vessels, reduce exudation and edema, relieve pain, reduce blister formation and prevent scars on the wound surfaces.
EXAMPLE seven
The embodiment provides a formula of a composition for removing necrotic tissue, promoting tissue regeneration and preventing scars, which comprises the following raw materials in parts by weight: 5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 1-1.2 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax. Through the quantitative compatibility of various traditional Chinese medicinal materials, the effective components of the raw medicinal materials generate obvious synergistic effect, have the effects of astringing, diminishing inflammation, removing the necrotic tissue, promoting granulation and removing heat toxin, are used for treating scalds or mechanical wounds, can quickly and thoroughly dissipate heat of the wounds, can cause the skin to contract blood vessels, reduce exudation and edema, relieve pain, reduce blister formation and prevent scars on the wound surfaces.
Example eight
The embodiment provides a formula of a composition for removing necrotic tissue, promoting tissue regeneration and preventing scars, which comprises the following raw materials in parts by weight: 5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 12-14 parts of sesame oil and 12-14 parts of beeswax. Through the quantitative compatibility of various traditional Chinese medicinal materials, the effective components of the raw medicinal materials generate obvious synergistic effect, have the effects of astringing, diminishing inflammation, removing the necrotic tissue, promoting granulation and removing heat toxin, are used for treating scalds or mechanical wounds, can quickly and thoroughly dissipate heat of the wounds, can cause the skin to contract blood vessels, reduce exudation and edema, relieve pain, reduce blister formation and prevent scars on the wound surfaces.
Example nine
The embodiment provides a formula of a composition for removing necrotic tissue, promoting tissue regeneration and preventing scars, which comprises the following raw materials in parts by weight: 5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12.5-13 parts of beeswax. Through the quantitative compatibility of various traditional Chinese medicinal materials, the effective components of the raw medicinal materials generate obvious synergistic effect, have the effects of astringing, diminishing inflammation, removing the necrotic tissue, promoting granulation and removing heat toxin, are used for treating scalds or mechanical wounds, can quickly and thoroughly dissipate heat of the wounds, can cause the skin to contract blood vessels, reduce exudation and edema, relieve pain, reduce blister formation and prevent scars on the wound surfaces.
Finally, it should be noted that: the above embodiments are only used to illustrate the technical solution of the present invention, and not to limit the same; while the invention has been described in detail and with reference to the foregoing embodiments, it will be understood by those skilled in the art that: the technical solutions described in the foregoing embodiments may still be modified, or some or all of the technical features may be equivalently replaced; and the modifications or the substitutions do not make the essence of the corresponding technical solutions depart from the scope of the technical solutions of the embodiments of the present invention.

Claims (9)

1. The formula of the composition for removing the necrotic tissue, promoting tissue regeneration and preventing scars is characterized by comprising the following raw materials in parts by weight:
5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax.
2. The composition formula for removing the necrotic tissue and promoting tissue regeneration and preventing scars as claimed in claim 1, which is characterized by comprising the following raw materials in parts by weight:
6.8-7.2 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax.
3. The composition formula for removing the necrotic tissue and promoting tissue regeneration and preventing scars as claimed in claim 1, which is characterized by comprising the following raw materials in parts by weight:
5-8.5 parts of borneol, 9.2-10.5 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax.
4. The composition formula for removing the necrotic tissue and promoting tissue regeneration and preventing scars as claimed in claim 1, which is characterized by comprising the following raw materials in parts by weight:
5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 16.5-16.8 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax.
5. The composition formula for removing the necrotic tissue and promoting tissue regeneration and preventing scars as claimed in claim 1, which is characterized by comprising the following raw materials in parts by weight:
5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22.5-23.2 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax.
6. The composition formula for removing the necrotic tissue and promoting tissue regeneration and preventing scars as claimed in claim 1, which is characterized by comprising the following raw materials in parts by weight:
5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7.8-8.2 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax.
7. The composition formula for removing the necrotic tissue and promoting tissue regeneration and preventing scars as claimed in claim 1, which is characterized by comprising the following raw materials in parts by weight:
5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 1-1.2 parts of narcissus, 10-20 parts of sesame oil and 12-14 parts of beeswax.
8. The composition formula for removing the necrotic tissue and promoting tissue regeneration and preventing scars as claimed in claim 1, which is characterized by comprising the following raw materials in parts by weight:
5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 12-14 parts of sesame oil and 12-14 parts of beeswax.
9. The composition formula for removing the necrotic tissue and promoting tissue regeneration and preventing scars as claimed in claim 1, which is characterized by comprising the following raw materials in parts by weight:
5-8.5 parts of borneol, 8-12 parts of angelica dahurica, 15-19 parts of dragon's blood, 22-23.5 parts of deerhorn glue, 7-8.5 parts of medical stone, 0.8-1.5 parts of narcissus, 10-20 parts of sesame oil and 12.5-13 parts of beeswax.
CN202010015411.3A 2020-01-07 2020-01-07 Composition formula for removing necrotic tissue, promoting granulation and preventing scars Pending CN111000933A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010015411.3A CN111000933A (en) 2020-01-07 2020-01-07 Composition formula for removing necrotic tissue, promoting granulation and preventing scars

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010015411.3A CN111000933A (en) 2020-01-07 2020-01-07 Composition formula for removing necrotic tissue, promoting granulation and preventing scars

Publications (1)

Publication Number Publication Date
CN111000933A true CN111000933A (en) 2020-04-14

Family

ID=70120663

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010015411.3A Pending CN111000933A (en) 2020-01-07 2020-01-07 Composition formula for removing necrotic tissue, promoting granulation and preventing scars

Country Status (1)

Country Link
CN (1) CN111000933A (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102274371A (en) * 2011-08-12 2011-12-14 冉好强 Ointment for treating burn, traumatic infection and pressure sore
CN103405731A (en) * 2013-06-27 2013-11-27 刘清 External unguent for treating scald and burn and preparation method thereof
CN108704017A (en) * 2018-06-01 2018-10-26 杨晓白 A kind of pharmaceutical composition and its preparation method and application removed necrosis and promoted granulation
CN108926704A (en) * 2018-08-06 2018-12-04 纪永利 A kind of skin wounds and ulcers wound is removed necrosis and promoted granulation the preparation method of spray
CN109528898A (en) * 2019-01-16 2019-03-29 王道福 A kind of wound myogenic cream

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102274371A (en) * 2011-08-12 2011-12-14 冉好强 Ointment for treating burn, traumatic infection and pressure sore
CN103405731A (en) * 2013-06-27 2013-11-27 刘清 External unguent for treating scald and burn and preparation method thereof
CN108704017A (en) * 2018-06-01 2018-10-26 杨晓白 A kind of pharmaceutical composition and its preparation method and application removed necrosis and promoted granulation
CN108926704A (en) * 2018-08-06 2018-12-04 纪永利 A kind of skin wounds and ulcers wound is removed necrosis and promoted granulation the preparation method of spray
CN109528898A (en) * 2019-01-16 2019-03-29 王道福 A kind of wound myogenic cream

Similar Documents

Publication Publication Date Title
Bardy et al. A systematic review of honey uses and its potential value within oncology care
Altman et al. A treatment algorithm to identify therapeutic approaches for leg ulcers in patients with sickle cell disease
Avijgan Phytotherapy: an alternative treatment for non-healing ulcers
Gayratovna WAYS OF OPTIMIZATION OF LOCAL THERAPY FOR PURULENT-INFLAMMATORY DISEASES OF THE MAXILLOFAQIAL REGION
CN102379896B (en) A kind of pharmaceutical composition making pathological tissues dehydration, atrophy, elimination
CN111000933A (en) Composition formula for removing necrotic tissue, promoting granulation and preventing scars
CN103705678A (en) Traditional Chinese medicinal oil for treating bedsores
US10232004B2 (en) Pharmaceutical composition based on Centella asiatica (Hydrocotyle asiatica L.) for the treatment of lower limb ulcers
CN1072499C (en) External-use medicine for curing various chronic ulcers
CN101869578B (en) External liniment for drawing pus out and diminishing inflammation
WO2006099789A1 (en) A pharmaceutical preparation
CN1186068C (en) Externally applied Chinese medicine with functions of diminishing inflammation, promoting granulation, stopping itch and stopping pain and its prepn process
CN104324230B (en) A kind of Externally applied Chinese medicine for treating the diabetes ulceration surface of a wound
RU2546030C1 (en) Ichthyosin preparation
PLANINŠEK RUČIGAJ et al. COMPARATIVE EFFECTS OF HONEY BASED AND SILVER/CHARCOAL BASED DRESSINGS ON THE HEALING OFVENOUS LEG ULCERS
CN107375704B (en) A topical Chinese medicinal powder for treating malignant body surface ulcer in combination with radiotherapy
CN101647851B (en) Medicament for treating burn and scald and preparation method thereof
CN105168510A (en) Traditional Chinese medicinal preparation for treating trauma
Giri Role of Ayurvedic Treatments–Ksharakarma (Caustic Cautery) and Jalukavacharana (Hirudotherapy) in the management of Necrotising Fascitis–A case Study
CN116898932A (en) External wound medicine and preparation method thereof
WATER E-POSTER SESSION: DIABETIC FOOT
CN114617929A (en) Medicinal liquor for treating chronic rhinitis and preparation method thereof
Kulesza et al. Treatment of lower limb trophic ulcers using hyperbaric oxygenation
CN111956748A (en) Medicament for treating burn and scar
Horaginamath et al. Effect of Talisadi Taila in the management of Sadhyo Vrana-A Case Study

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20200414